Vertex Pharmaceuticals
VRTX
VRTX
679 hedge funds and large institutions have $39.3B invested in Vertex Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 96 funds opening new positions, 242 increasing their positions, 241 reducing their positions, and 55 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more repeat investments, than reductions
Existing positions increased: 242 | Existing positions reduced: 241
0.23% more ownership
Funds ownership: 94.77% → 95% (+0.23%)
15% less call options, than puts
Call options by funds: $188M | Put options by funds: $220M
Holders
679
Holding in Top 10
11
Calls
$188M
Puts
$220M
Top Buyers
| 1 | +$507M | |
| 2 | +$248M | |
| 3 | +$202M | |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
+$167M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$150M |
Top Sellers
| 1 | -$230M | |
| 2 | -$213M | |
| 3 | -$153M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$153M |
| 5 |
Two Sigma Investments
New York
|
-$142M |